Sruthi Arepalli, MD

Articles by Sruthi Arepalli, MD

Optimizing Treatment Outcomes in Retinal Vein Occlusion (RVO)

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Geeta Lalwani, MD

August 14th 2024

A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.

Optimizing Treatment Outcomes in Retinal Vein Occlusion

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Geeta Lalwani, MD

August 1st 2024

A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.

A panel of 3 experts on ocular diseases and conditions

Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and Diabetic Macular Edema

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Rishi P. Singh, MD

July 10th 2024

A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.

Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Rishi P. Singh, MD

July 1st 2024

A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.

Hong-Uyen Hua, MD; Sruthi Arepalli, MD; and Peter Kaiser, MD

Generational Trends and Innovations in Retinal Disease Treatment

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Peter Kaiser, MD

June 18th 2024

A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.

Generational Trends and Innovations in Retinal Disease Care

ByHong-Uyen Hua, MD,Sruthi Arepalli, MD,Peter Kaiser, MD

June 3rd 2024

A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.